Related Experiment Videos
Preliminary experiences with the Orbis-Sigma-System as a ventriculo-peritoneal shunt
Summary
The Orbis-Sigma shunt system shows promise for treating hydrocephalus in children. Preliminary results indicate its effectiveness in managing cerebrospinal fluid pressure, with further analysis of revision rates ongoing.
Area of Science:
- Neurosurgery
- Pediatric Neurology
- Biomedical Engineering
Background:
- Hydrocephalus is a condition characterized by excess cerebrospinal fluid (CSF) in the brain.
- Shunt systems are crucial for managing hydrocephalus by draining excess CSF.
- The Orbis-Sigma system is a newer shunt technology for hydrocephalus treatment.
Purpose of the Study:
- To evaluate the clinical utility and preliminary outcomes of the Orbis-Sigma shunt system in pediatric hydrocephalus.
- To assess the frequency and causes of shunt revisions in children treated with the Orbis-Sigma system.
Main Methods:
- A cohort of 40 hydrocephalic children received Orbis-Sigma shunt implantation over 3 years.
- Patients underwent regular clinical assessments, head circumference measurements, and imaging (ultrasonography or CT).
- Shunt revision rates and reasons were systematically recorded and analyzed.
Main Results:
- The Orbis-Sigma system was implanted as a primary shunt in 28 children and as a secondary shunt in 12.
- A mean follow-up period of 1.4 years was achieved for the cohort.
- Data on clinical effectiveness and revision frequency are currently being compiled and discussed.
Conclusions:
- The Orbis-Sigma shunt system demonstrates potential as an effective treatment for pediatric hydrocephalus.
- Further analysis of long-term outcomes and revision data is necessary to fully establish its efficacy and safety profile.